How health literacy can enhance the design and conduct of clinical trials from consent to conclusion

被引:0
|
作者
O'Leary C. [1 ]
Casey C. [1 ]
Webb D. [1 ]
Collyar D. [2 ]
Pleasant A. [1 ]
机构
[1] Health Literacy Media, 911 Washington Avenue, St. Louis, MO
[2] Patient Advocates in Research, San Francisco, CA
来源
Information Services and Use | 2020年 / 40卷 / 1-2期
关键词
clinical trials; Health literacy; plain language; science communication;
D O I
10.3233/ISU-200082
中图分类号
学科分类号
摘要
Health literacy research and interventions have provided multiple tools to improve communication between professionals and patients in clinical contexts for many years. Despite the reality that many patients participate in clinical trials in conjunction with standard medical care, only recently have efforts extended to address and improve the health literacy of both clinical trial researchers and participants. To date, the primary focus of health literacy activities in clinical trials has centered on communicating trial results to trial participants. This report describes the opportunities and strategies necessary to layer health literacy activities across the clinical trial process from consent to conclusion. © 2020-IOS Press and the authors. All rights reserved.
引用
下载
收藏
页码:41 / 49
页数:8
相关论文
共 50 条
  • [11] Role of Health Literacy on Perception of Voluntariness During Informed Consent for Pediatric Cancer Clinical Trials
    Aristizabal, P.
    Ma, A.
    Perdomo, P.
    Martinez, M. E.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S117 - S117
  • [12] Simplification improves understanding of informed consent information in clinical trials regardless of health literacy level
    Kim, Eun Jin
    Kim, Su Hyun
    CLINICAL TRIALS, 2015, 12 (03) : 232 - 236
  • [13] How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis
    Flight, Laura
    Julious, Steven
    Brennan, Alan
    Todd, Susan
    Hind, Daniel
    TRIALS, 2020, 21 (01)
  • [14] How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis
    Laura Flight
    Steven Julious
    Alan Brennan
    Susan Todd
    Daniel Hind
    Trials, 21
  • [15] A CALL TO ACTION: HOW CAN CONGRESS HELP ENHANCE DIVERSITY IN CLINICAL TRIALS?
    Gupta, Megha
    Vardeny, Orly
    Ibrahim, Nasrien E.
    Fiuzat, Mona
    Blumer, Vanessa
    Leifer, Eric
    Jessup, Mariell
    Dimond, Matthew
    Adamson, Philip B.
    Lindenfeld, JoAnn
    O'Connor, Christopher M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 726 - 726
  • [16] CLINICAL TRIALS IN ADPKD-HOW TO CONDUCT GOOD CLINICAL TRIALS IN ADPKD?
    Hawley, Carmel
    NEPHROLOGY, 2021, 26 : 15 - 16
  • [17] DESIGN AND CONDUCT OF CLINICAL TRIALS IN MYOCARDIAL INFARCTION
    REID, DD
    CIRCULATION, 1969, 40 (5S4) : IV91 - &
  • [18] DESIGN AND CONDUCT OF CLINICAL-TRIALS IN OSTEOARTHRITIS
    ALTMAN, RD
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1990, : 24 - 27
  • [19] A primer on the design, conduct, and interpretation of clinical trials
    Appel, Lawrence J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (06): : 1360 - 1367
  • [20] ISSUES IN THE DESIGN AND CONDUCT OF CLINICAL-TRIALS
    HENNEKENS, CH
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1984, 73 (06) : 1473 - 1476